Armand Butera
MD Magazine
Contact Armand
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Armand:
Rasika Mathias, PhD: Detailing the LEAP Study
Dr. Mathias noted that investigators are continuing to determine if age plays a role in peanut allergy risk and sensitization. → Read More
Megha Shankar, MD: Promoting Antiracism Practices in Health Care
Dr. Shankar speaks to how physician training and patient conversations can evolve in dermatology through progressive antiracism efforts. → Read More
J. Allen Meadows, MD: Allergy Care During the COVID-19 Pandemic
Dr. Meadows noted that patients with allergies have historically had the option of being treated through telemedicine, which has been more widely adopted during the COVID-19 pandemic. → Read More
FDA Approves Apremilast for Adult Patients with Plaque Psoriasis Across All Severities
Apremilast is now the first and only treatment approved in adult patients with plaque psoriasis across all severities. → Read More
David Rosmarin, MD: The Potential of Ruxolitinib for Vitiligo Management
Dr. Rosmarin details the TruE-V clinical trial, and speaks to what could eventually be the first FDA approved medicine for vitiligo. → Read More
First COVID-19 Case Originated from Wuhan Market, Study Suggests
New developments in the origin of the SARS-CoV-2 virus reported today in the New York Times suggested that first known patient to have contracted the virus was a vendor in a sizeable animal market in Wuhan, China. Earlier suggestions made by the World Health Organization (WHO) believed the first known case to be an accountant who lived miles from the market. The new report was published Thursday… → Read More
Boni Elewski, MD: Safety and Efficacy of New Psoriasis Therapies
Certain biologics such as infliximab have aided psoriasis patients in the mitigation of symptoms from the COVID-19 virus. → Read More
Syed Shazhad Mustafa, MD: Advancing Pediatric Peanut Allergy Management
Dr. Mustafa speaks on new data related to peanut allergy and Palforzia therapy that were presented at the most recent ACAAI session. → Read More
Educational, Psychological Interventions Reduce Atopic Dermatitis Severity
Investigators believe that pediatric patients can gain the most from a combination of interventions, though larger studies are needed to confirm the data. → Read More
Lack of Specialist Care, Low CAM Ratio Associated with Pediatric Asthma
Dr. Owotomo and fellow investigators evaluated 1298 children from the Washington DC area and found that called for greater asthma care by pulmonologists and allergists alike. → Read More
Patients with Alopecia Areata at Increased Risk of Thyroid Disease
Investigators also found that patients with alopecia areata were also had significant inflammatory immune injury and vitamin D deficiency when compared to healthy subjects. → Read More
Amy Paller, MD: Evaluating the Impact of Atopic Dermatitis on Pediatric Patients
Dr. Paller speaks of the AD-GAP study, which shared insights on moderate to severe atopic dermatitis from patients, caregivers, and independent physicians. → Read More
Early Systemic Glucocorticoid Treatment Suggested for Vitiligo Patients
Investigators reported a significant difference in the expansion rate of the skin lesion area in patients with vitiligo in just 3 months of treatment. → Read More
Patients with Persistent Cough Prone to Severe Asthma Presentation
Investigators believe these findings can help identify high-risk groups and prevent exacerbations through tailored treatments. → Read More
Laboratory Markers Aid in Evaluating Atopic Dermatitis
Investigators added that the meaning of each laboratory marker is dependent on the drug that is being used for treatment. → Read More
FDA Approves Ruxolitinib for Patients with Chronic Graft-Versus-Host Disease
The drug is approved for adults and pediatric patients 12 years and older after the failure of 1 or 2 lines of systemic therapy. → Read More
Laurence Sperling, MD, FACC, FACP, FAHA: Optimizing Cardiovascular Care
In his recent presentation, Dr. Sperling spoke of how a greater focus needed to be made on the implementation of cardiovascular care strategies, as well as better utilization of health system approaches. → Read More
FDA Approves Ruxolitinib for Mild to Moderate Atopic Dermatitis
The approval follows recent phase 3 trial data showing significant improvement in patient-reported outcomes for the treatment of atopic dermatitis. → Read More
Significant Educational Gaps in Allergy Research Recorded in Europe
Investigators report that few medical schools in Europe consider allergology to be an important area of study, resulting in a lack of knowledge regarding certain allergy practices. → Read More
Potential Risks of CVD in Women with Polycystic Ovary Syndrome
Though limited data exist, Dr. Dunfaif believes there’s are indications of cardiovascular risk in patients of all ages with polycystic ovary syndrome. → Read More